COMPASS Pathways plc (NASDAQ:CMPS) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET
Company Participants
Steven Schultz - SVP, IR
George Goldsmith - Co-Founder and Executive Chairman
Kabir Nath - CEO
Guy Goodwin - Chief Medical Officer
Mike Falvey - CFO
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Neena Bitritto-Garg - Citi
Ritu Baral - Cowen
Patrick Trucchio - H.C. Wainwright & Company
François Brisebois - Oppenheimer
Bert Hazlett - BTIG
Esther Hong - Loop Capital
Sumant Kulkarni - Canaccord Genuity
Michael Okunewitch - Maxim Group
Operator
Good day, ladies and gentlemen, and welcome to the COMPASS conference Third Quarter Call. [Operator Instructions] As a reminder, this call is being recorded.
And I would now like to introduce your host for today's conference, Steven Schultz. Sir, you may begin.
Steven Schultz
Welcome all of you, and thank you for joining us today for our third quarter 2022 results conference call. We hope you've had a chance to review the two press releases we issued earlier today, summarizing our accomplishments this quarter and announcing the publication of the results of our Phase 2b trial for treatment-resistant depression in The New England Journal of Medicine.
Again, my name is Steven Schultz, Senior Vice President of Investor Relations at COMPASS Pathways. And today, I'm joined by George Goldsmith, our Co-Founder and Executive Chairman; our Chief Executive Officer, Kabir Nath; Dr. Guy Goodwin, Chief Medical Officer; and Mike Falvey, our Chief Financial Officer.
The call is being recorded and will be available on the COMPASS Pathways Investor Relations website shortly after the conclusion of the call.
Before we begin, let me remind everyone that during the call today, the team will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as amended. You should not place undue reliance on these forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those risks and uncertainties described under the heading Risk Factors in our quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission and in subsequent filings made by COMPASS with the SEC.
Additionally, these forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements, even if our estimates or assumptions change.